Real-world study of adverse events associated with gepant use in migraine treatment based on the VigiAccess and U.S. Food and Drug Administration’s adverse event reporting system databasesQiaofang Liang, Hailong Li, Taolin Liang et al.|Frontiers in Pharmacology|2024Cited by 30
Safety study on adverse events of zanubrutinib based on WHO-VigiAccess and FAERS databasesQiaofang Liang, Hongwen Wu, Xiaolin Liao et al.|Expert Opinion on Drug Safety|2024Cited by 8